Fatty acid nitroalkene reversal of established lung fibrosis

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Luca Richeldi, Roland M. du Bois, Ganesh Raghu et al. · New England Journal of Medicine · 2014 · 4.4K citations · Full text

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

Paul W. Noble, Carlo Albera, Williamson Z. Bradford et al. · The Lancet · 2011 · 2.1K citations

Antifibrotic Therapy, Idiopathic Pulmonary Fibrosis, Pharmacology +6

Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Arata Azuma, Toshihiro Nukiwa, Eiyasu Tsuboi et al. · American Journal of Respiratory and Critical Care Medicine · 2005 · 944 citations

Acute Lung Injury, Fatal Disorder, Antifibrotic Therapy +16

Pirfenidone in idiopathic pulmonary fibrosis

H. Taniguchi, Masahito Ebina, Yasuhiro Kondoh et al. · European Respiratory Journal · 2009 · 933 citations · Full text

Antifibrotic and Anti-inflammatory Activity of the Tyrosine Kinase Inhibitor Nintedanib in Experimental Models of Lung Fibrosis

Lutz Wollin, Isabelle Maillet, Valérie Quesniaux et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 610 citations